Statement·other·said 2019-04-22
“Big pharmaceuticals pay off — they literally pay off — generics to keep the prices and the competition off the market.”
Proof of utterancewhere they said it
Verdict
Trueby PolitiFact
2019-04-25Reasoning
Pay-for-delay is real: brand-name drugmakers compensate generics to delay market entry. Since the 2013 FTC v. Actavis Supreme Court ruling, payments may take non-cash forms but the practice continues.
Proof of outcomewhat backs the verdict